Home » Topics » BioWorld Science

BioWorld Science
RSS

New IRAK and FLT3 inhibitors described by U.S. investigators

Feb. 23, 2022

Columbia University discloses CD33/CD45 interaction inhibitors

Feb. 23, 2022

U.S. researchers divulge CDK19 inhibitors

Feb. 23, 2022

Ideaya Biosciences presents POLQ inhibitors

Feb. 23, 2022

Discovery of novel peptides as probes for crotamine

Feb. 23, 2022

S-05014, a novel tyrosinase inhibitor with promising anti-Parkinsonian activity

Feb. 23, 2022

MZE-001 shows promising results in murine and canine models of Pompe disease

Feb. 23, 2022

Blockade of HIF-1 leads to ROS overproduction in diabetes

Feb. 23, 2022

Engineered Wnt ligands repair BBB in neuro disorders

Feb. 22, 2022

NovoBiome and Inserm collaborate on intestinal organoid-on-a-chip technology

Feb. 22, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026